+1.14% for Abbott stock as sellers limit gains below key resistance levels

+1.14% for Abbott stock as sellers limit gains below key resistance levels
Abbott rises 1.14% today to $101.84

Abbott received the number one ranking in the health care sector and placed fourth overall on Fortune Magazine’s America’s Most Innovative Companies list.

Abbott said its health technology and products are developed with the goal of helping people live healthier, fuller lives. The company shared a link for more information.

Highlights

  • ABT remains under sustained seller pressure, consistently trading below all major moving averages and key resistance levels.
  • Bearish momentum persists with negative signals across MACD and ADX, while oversold readings suggest continued downside risk.
  • Expected range for the coming week is $99.00 to $105.00, with a higher probability of further downward movement unless $105.91 is reclaimed.

Seller control as price remains below key averages and resistance clusters

ABT is currently trading at $101.84, positioned below the SMA-20 ($104.27), SMA-50 ($108.81), and SMA-200 ($123.32). This setup suggests sustained seller pressure across all key timeframes. The Ichimoku Kijun sits at $105.91, acting as immediate resistance. Near-term support is seen at the SMA-5 ($101.81), while key support comes in at the SMA-50 ($108.81). Immediate resistance is marked by the Ichimoku Kijun ($105.91), with key resistance at the SMA-100 ($116.08).

Bearish momentum persists despite brief bounce and oversold signals

Momentum remains negative, with a firmly bearish MACD (D1) and ADX signaling persistent downtrend strength. On the D1, RSI is near oversold at 32.98, CCI confirms an oversold reading at −120.97, and BBP's strong negative value (−2.04) reflects seller dominance in recent sessions. The Stoch RSI delivers a neutral signal but with no confirmation of a reversal, while AO aligns with the prevailing bearish tone. In today’s session, ABT is up 1.14%, suggesting an attempt at a technical bounce. Over the past week, ABT has risen $1.54 (1.68%) from a previous weekly close of $100.30, with the current price positioned in the middle of this week’s range. Weekly volatility stands at 4.84%, reflecting moderate price swings and indicating a mild recovery from the weekly low.

Downside favored as ‘sell’ signals dominate and risk skew shifts lower

Looking ahead, the expected price range for the coming week is $99.00 to $105.00, keeping the outlook in line with observed weekly volatility and anchoring the forecast above the recent 52-week low ($99.05) but well below the 52-week high ($139.06). There is a very low probability (less than 20%) of a sustained price increase, with downside movement being much more likely, as confirmed by the "Sell" signals across all W1 indicators and moving averages. Baseline scenario: ABT trades sideways between $99.00 and $105.00. Bullish scenario: a break above $105.91 could see a move toward the $108.81 resistance cluster. Bearish scenario: failure to hold above $99.00 may lead to tests of new multi-month lows.

Earlier, analysts noted that Abbott Laboratories was experiencing persistent downside pressure and bearish momentum based on prevailing technical indicators. In light of current dynamics, investors should closely monitor for any shift in trend or a decisive break above immediate resistance, as such developments could signal an emerging reversal in the stock’s trajectory.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.